Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts
Document Type
Letter to the Editor
Publication Title
Cancer Research, Statistics, and Treatment
First Page
779
Last Page
780
DOI
10.4103/crst.crst_307_22
Publication Date
10-1-2022
Recommended Citation
Devaraja, K., "Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts" (2022). Open Access archive. 3865.
https://impressions.manipal.edu/open-access-archive/3865
COinS
